Literature DB >> 6803538

Macrophages from different sources, their production of chemiluminescence under various stimuli and the effects of PGE2 and drugs.

M J Parnham, C Bittner, J Winkelmann.   

Abstract

We are currently characterizing different macrophages sub-populations according to their release of oxygen free radicals (measured as chemiluminescence) under various stimuli and their responses to drugs and mediators. Mouse macrophages were obtained by peritoneal or lung lavage and stimulated in vitro with opsonized zymosan (OpZ) or the calcium ionophore A23187. Chemiluminescence was measured in a luminometer and responses obtained after 5 min expressed as percentages of standard responses to the stimuli. Almost identical dose-response curves to OpZ were obtained with peritoneal and alveolar macrophages, while the dose-response curve of peritoneal macrophages to A23187 was much shallower. The response to A23187 was generally much weaker than that to OpZ and in both types of macrophages PGE2 was a more effective inhibitor of OpZ-induced chemiluminescence than of that induced by A23187. The response to OpZ in peritoneal macrophages was inhibited in a dose-related manner by both PGE2 and superoxide dismutase, but not by indomethacin, d-penicillamine, piroxicam or phenylbutazone. OpZ but not A23187, is a suitable stimulus for pharmacological studies on macrophage chemiluminescence.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6803538     DOI: 10.1007/BF01978765

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes.

Authors:  J E Smolen; G Weissmann
Journal:  Biochem Pharmacol       Date:  1980-02-15       Impact factor: 5.858

2.  Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG.

Authors:  J E Lehmeyer; R B Johnston
Journal:  Clin Immunol Immunopathol       Date:  1978-04

3.  The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms.

Authors:  J L Humes; S Burger; M Galavage; F A Kuehl; P D Wightman; M E Dahlgren; P Davies; R J Bonney
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

4.  Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence.

Authors:  M J Weidemann; B A Peskar; K Wrogemann; E T Rietschel; H Staudinger; H Fischer
Journal:  FEBS Lett       Date:  1978-05-01       Impact factor: 4.124

5.  A new screening system for nonsteroidal anti-inflammatory drugs based upon inhibition of chemiluminescence produced from human cells (granulocytes).

Authors:  K Van Dyke; C Van Dyke; J Udeinya; C Brister; M Wilson
Journal:  Clin Chem       Date:  1979-09       Impact factor: 8.327

6.  Cyclic AMP in macrophages from experimental granulomas and the effect of prostaglandin E2.

Authors:  M J Adolfs; I L Bonta; M J Parnham
Journal:  Agents Actions       Date:  1980-12

7.  Hydrogen peroxide-releasing function of chemically elicited and immunologically activated macrophages: differential response to wheat germ lectin and concanavalin A.

Authors:  H Tomioka; H Saito
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

  7 in total
  3 in total

Review 1.  Regulatory aspects of low intensity photon emission.

Authors:  R Van Wijk; D H Schamhart
Journal:  Experientia       Date:  1988-07-15

2.  Exaggerated hypotension by N-formylmethionylleucyl-phenylalanine in indomethacin pretreated rats. Role of toxic oxygen.

Authors:  U B Olsen; V Bille-Hansen
Journal:  Agents Actions       Date:  1986-03

Review 3.  Ultraweak photon emission as a non-invasive health assessment: a systematic review.

Authors:  John A Ives; Eduard P A van Wijk; Namuun Bat; Cindy Crawford; Avi Walter; Wayne B Jonas; Roeland van Wijk; Jan van der Greef
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.